These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 20463439)
21. Relationship of bone turnover to bone density and fractures. Melton LJ; Khosla S; Atkinson EJ; O'Fallon WM; Riggs BL J Bone Miner Res; 1997 Jul; 12(7):1083-91. PubMed ID: 9200008 [TBL] [Abstract][Full Text] [Related]
22. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. Liberman UA; Weiss SR; Bröll J; Minne HW; Quan H; Bell NH; Rodriguez-Portales J; Downs RW; Dequeker J; Favus M N Engl J Med; 1995 Nov; 333(22):1437-43. PubMed ID: 7477143 [TBL] [Abstract][Full Text] [Related]
24. Influence of body parameters on female peak bone mass and bone loss. Ortolani S; Trevisan C; Bianchi ML; Gandolini G; Cherubini R; Polli EE Osteoporos Int; 1993; 3 Suppl 1():61-6. PubMed ID: 8461579 [No Abstract] [Full Text] [Related]
25. The hypothalamic control of bone mass, implication for the treatment of osteoporosis. Karsenty G; Ducy P Ann Endocrinol (Paris); 2006 Apr; 67(2):123. PubMed ID: 16639361 [No Abstract] [Full Text] [Related]
26. There is an age-related increase in corticosteroid secretion in rats. Could a similar increase with age predispose postmenopausal women to develop osteoporosis? Hicks BH Br J Rheumatol; 1991 Apr; 30(2):90. PubMed ID: 2012962 [No Abstract] [Full Text] [Related]
27. More Evidence of the Association of Depression With Adherence to Medical Therapies in Coronary Heart Disease. Carney RM JAMA Netw Open; 2022 Dec; 5(12):e2246324. PubMed ID: 36508220 [No Abstract] [Full Text] [Related]
28. Comments on 'Potential risk factors for birth fractures: a case-control study'. Safiri S; Ayubi E; Mansori K Int Orthop; 2018 Feb; 42(2):449. PubMed ID: 29181562 [No Abstract] [Full Text] [Related]
29. Evaluation of the effects of β1-selective beta-blockers on bone mineral density and fracture risk in postmenopausal women. Yavuz Keleş B; Vural M; Önder B; Öneş K Turk J Med Sci; 2020 Jun; 50(4):994-998. PubMed ID: 32283907 [TBL] [Abstract][Full Text] [Related]
30. Effect of Beta-Blockers on Number of Osteoblasts and Osteoclasts in Alveolar Socket Following Tooth Extraction in Wistar Rats. Sadr K; Aghbali A; Sadr M; Abachizadeh H; Azizi M; Mesgari Abbasi M J Dent (Shiraz); 2017 Mar; 18(1):37-42. PubMed ID: 28280758 [TBL] [Abstract][Full Text] [Related]
31. Relationship between autonomic nervous system activity and bone mineral density in non-medicated perimenopausal women. Miyasaka N; Akiyoshi M; Kubota T J Bone Miner Metab; 2014 Sep; 32(5):588-92. PubMed ID: 24202063 [TBL] [Abstract][Full Text] [Related]
32. β-Adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effects. Toulis KA; Hemming K; Stergianos S; Nirantharakumar K; Bilezikian JP Osteoporos Int; 2014 Jan; 25(1):121-9. PubMed ID: 24114396 [TBL] [Abstract][Full Text] [Related]
33. Heart failure as a risk factor for osteoporosis and fractures. Aluoch AO; Jessee R; Habal H; Garcia-Rosell M; Shah R; Reed G; Carbone L Curr Osteoporos Rep; 2012 Dec; 10(4):258-69. PubMed ID: 22915207 [TBL] [Abstract][Full Text] [Related]
34. Peptic ulcer disease and heart disease are associated with periprosthetic fractures after total hip replacement. Singh JA; Lewallen DG Acta Orthop; 2012 Aug; 83(4):353-9. PubMed ID: 22900908 [TBL] [Abstract][Full Text] [Related]
35. Treated Hypertension has No Influence on the Efficacy of Alendronate in the Therapy of Postmenopausal Osteoporosis: A Non-Randomized, Non-Blind, Controlled Prospective Study. Matziolis D; Drewke M; Matziolis G; Perka C Open Orthop J; 2011 Jan; 5():27-31. PubMed ID: 21270954 [TBL] [Abstract][Full Text] [Related]
36. Beta-blocker use is associated with fragility fractures in postmenopausal women with coronary heart disease. Sosa M; Saavedra P; Gómez de Tejada MJ; Mosquera J; Pérez-Cano R; Olmos JM; Muñoz-Torres M; Amérigo MJ; Moro MJ; Díaz-Curiel M; Alegre J; Malouf J; Del Pino J; Nogués X; Torrijos A; Aging Clin Exp Res; 2011 Apr; 23(2):112-7. PubMed ID: 20463439 [TBL] [Abstract][Full Text] [Related]
37. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study. Garnero P; Cloos P; Sornay-Rendu E; Qvist P; Delmas PD J Bone Miner Res; 2002 May; 17(5):826-33. PubMed ID: 12009013 [TBL] [Abstract][Full Text] [Related]
38. Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study. Sornay-Rendu E; Munoz F; Duboeuf F; Delmas PD J Bone Miner Res; 2005 Nov; 20(11):1929-35. PubMed ID: 16234965 [TBL] [Abstract][Full Text] [Related]
39. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. Sinigaglia L; Nervetti A; Mela Q; Bianchi G; Del Puente A; Di Munno O; Frediani B; Cantatore F; Pellerito R; Bartolone S; La Montagna G; Adami S J Rheumatol; 2000 Nov; 27(11):2582-9. PubMed ID: 11093437 [TBL] [Abstract][Full Text] [Related]
40. Protective effect of beta blockers in postmenopausal women: influence on fractures, bone density, micro and macroarchitecture. Bonnet N; Gadois C; McCloskey E; Lemineur G; Lespessailles E; Courteix D; Benhamou CL Bone; 2007 May; 40(5):1209-16. PubMed ID: 17324648 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]